gvtcx

LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient (API), Resveratrol: the COLO-PREVENT study

University of Leicester Published 14 Oct 2021 Contracts Finder

key details

Value£1,057,433
Statuscomplete
Category (CPV) 73000000
Deadline6 May 2021
Procedureopen
OCIDocds-h6vhtk-02a187

Awards (2)

This procurement was awarded to 1 suppliers. Values shown are per-award; the notice total is £1,057,433.

SupplierValueDateStatus
Catalent Nottingham Limited £1,057,433 12 Oct 2021 active
Catalent Nottingham Limited · · active

description

LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient (API), Resveratrol: the COLO-PREVENT study

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

4 notices published against this procurement.

PublishedTypeRegimeNotice
31 Mar 2021 Contract notice (F02) Earlier regulations 006678-2021
31 Mar 2021 Tender (tender) · 863e46f4-bd31-4d8e-b7c4-9d793deb91b4-425254
14 Oct 2021 Contract award notice (F03) Earlier regulations 025703-2021
14 Oct 2021 Award (award) · d9194bc4-e0fb-484f-80b3-7768a9e72fd9-476697

more from University of Leicester

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.